Status:

RECRUITING

Norepinephrine Equivalent Dose of Vasopressin, Phenylephrine and Epinephrine in Septic Shock

Lead Sponsor:

Sanjay Gandhi Postgraduate Institute of Medical Sciences

Conditions:

Septic Shock

Eligibility:

All Genders

18-80 years

Brief Summary

Septic shock is the most common form of circulatory shock encountered in patients admitted in intensive care unit. The initial management involves fluid resuscitation but if hypotension does not get r...

Detailed Description

Sepsis is a life-threatening state of organ dysfunction caused by dysregulated response of host to infection. It is the most common form of circulatory shock encountered in patients admitted in intens...

Eligibility Criteria

Inclusion

  • All adult patients on mechanical ventilation in septic shock receiving norepinephrine in whom the treating clinical team plan to add another vasopressor, will be considered for inclusion if they meet these two condition (1) Patient is on Norepinephrine infusion at least 0.1 mcg/kg/min for the last 6 hours; and (2) There has been no dose alteration in the infusion of norepinephrine for the last 2 hours

Exclusion

  • There are concurrently other forms of shock like cardiogenic, obstructive, anaphylactic or hypovolemic.
  • The patient has arrhythmias during the current course of illness.
  • The patient has asynchrony on mechanical ventilator despite airway clearance with suctioning and adequate sedation at the time of study measurement.
  • The patient is hypovolemic with ongoing fluid resuscitation in the form of fluid boluses, blood or blood product transfusions at the time of study measurement.
  • The patient receives diuretic boluses or undergoes hemodialysis sessions at the time of study measurement.
  • Pregnancy
  • Patient who didn't consent for study or withdrew the consent at any point of the study.

Key Trial Info

Start Date :

July 12 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06499467

Start Date

July 12 2024

End Date

January 1 2026

Last Update

July 16 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sanjay Gandhi Postgraduate Institute of Medical Sciences

Lucknow, Uttar Pradesh, India, 226014